Moderna Stock Is Up 770% in 2026 and Jumped Again on Q3 Profit

Moderna (MRNA) rose about 7% on Fri, Nov 6, 2026, to about $258, adding more than $6B in market value.

November 6, 2026 · 56 views · YouTube video: Moderna Is Up 770% in 2026. And It Jumped Again

Watch on YouTube · Subscribe to @PROOFOFDATA

Quick overview

Moderna rose about 7% on Nov 6, 2026, to about $258, adding more than $6B in market value intraday.
From $29.49 at the start of 2026, the stock is up more than 750%, but still about half its 2021 record.
Q3 revenue of $1.31B beat ~$885M expected, with $162M net income and a raised 2026 growth outlook.

+7% Move on Nov 6, 2026 (to ~$258, intraday)
+770% Gain in 2026 from $29.49
$1.31B Q3 revenue vs ~$885M expected

What happened

Moderna jumped about 7% to roughly $258 by about 1:15 PM ET on Friday, Nov 6, 2026, adding more than $6B in market value (Yahoo Finance prices and shares). The stock closed 2025 at $29.49, so at $258 it is up about 770% this year.

The trigger was Q3 2026: revenue of $1.31B against about $885M expected, net income of $162M, and a raised 2026 revenue growth outlook of 15% to 25%, as reported by CNBC.

Why it matters

Even after this run, Moderna sits at about half its record close of $484.47 from Aug 9, 2021, at the pandemic peak. Much of the 2026 rally has been driven by hopes for its personalized cancer vaccine with Merck, so the profit surprise adds earnings support to a story that was largely about the pipeline.

Watch the 30-second breakdown on YouTube and see the full Moderna chart.

FAQ

Why is Moderna stock up so much in 2026?

The rally has been driven largely by hopes for its personalized cancer vaccine with Merck (reported). On Nov 6, 2026, a surprise Q3 profit of $162M, revenue of $1.31B vs about $885M expected, and a raised 2026 outlook added another ~7%. Not financial advice.